Patents by Inventor Mariona Pascal Capdevila

Mariona Pascal Capdevila has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240398945
    Abstract: The present invention refers to a CD19-specific chimeric antigen receptor (CAR) T-cell therapy and to its use for treating CD19+ malignancies.
    Type: Application
    Filed: May 6, 2022
    Publication date: December 5, 2024
    Inventors: Manel JUAN OTERO, Álvaro URBANO ISPIZUA, Mariona PASCAL CAPDEVILA, Jordi YAGÜE RIBES, Julio DELGADO GONZÁLEZ, Jordi ESTEVE REYNER, María CASTELLÀ CASTELLÀ, Ana BORONAT BARADO
  • Patent number: 11598772
    Abstract: A diagnostically useful carrier includes a means for specifically capturing an antibody to a polypeptide from the group including squid MLC1 or squid MLC2 or a variant thereof in a sample from a subject. A method includes the step detecting in a sample from a subject the presence or absence of an antibody to squid MLC1 or squid MLC2. The polypeptide or the carrier or a polypeptide binding specifically to an IgE antibody from the sample of a patient to squid MLC1 or squid MLC2 are useful for the manufacture of a diagnostic kit, preferably for the diagnosis of allergy.
    Type: Grant
    Filed: June 17, 2020
    Date of Patent: March 7, 2023
    Assignees: EUROIMMUN Medizinische Labordiagnostika AG, Hospital Clinic de Barcelona, Institut D'Investigacions Biomédiques August Pi i Sunyer
    Inventors: Waltraud Suer, Marco Klinge, Alf Weimann, Stefanie Rohwer, Henning Seismann, Mariona Pascal Capdevila
  • Publication number: 20210333274
    Abstract: A diagnostically useful carrier includes a means for specifically capturing an antibody to a polypeptide from the group including squid MLC1 or squid MLC2 or a variant thereof in a sample from a subject. A method includes the step detecting in a sample from a subject the presence or absence of an antibody to squid MLC1 or squid MLC2. The polypeptide or the carrier or a polypeptide binding specifically to an IgE antibody from the sample of a patient to squid MLC1 or squid MLC2 are useful for the manufacture of a diagnostic kit, preferably for the diagnosis of allergy.
    Type: Application
    Filed: June 17, 2020
    Publication date: October 28, 2021
    Applicant: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Waltraud Suer, Marco Klinge, Alf Weimann, Stefanie Rohwer, Henning Seismann, Mariona Pascal Capdevila
  • Publication number: 20200400665
    Abstract: A diagnostically useful carrier includes a means for specifically capturing an antibody to a polypeptide from the group including squid MLC1 or squid MLC2 or a variant thereof in a sample from a subject. A method includes the step detecting in a sample from a subject the presence or absence of an antibody to squid MLC1 or squid MLC2. The polypeptide or the carrier or a polypeptide binding specifically to an IgE antibody from the sample of a patient to squid MLC1 or squid MLC2 are useful for the manufacture of a diagnostic kit, preferably for the diagnosis of allergy.
    Type: Application
    Filed: June 17, 2020
    Publication date: December 24, 2020
    Applicant: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Waltraud Suer, Marco Klinge, Alf Weimann, Stefanie Rohwer, Henning Seismann, Mariona Pascal Capdevila